Pramlintide Acetate Injection shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting Oct 27, 2025 · last update Oct 27, 2025
Manufacturers: AstraZeneca AB
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02) | AstraZeneca AB | To Be Discontinued | — | Discontinuation of the manufacture of the drug. | Posted Oct 27, 2025 Updated Oct 27, 2025 Discontinued Oct 27, 2025 |
| SymlinPen® 120 , Injection, 1000 ug/1 mL (NDC 0310-6627-02) | AstraZeneca AB | To Be Discontinued | — | Discontinuation of the manufacture of the drug. | Posted Oct 27, 2025 Updated Oct 27, 2025 Discontinued Oct 27, 2025 |